Surgery Partners (SGRY) Cash from Investing Activities (2014 - 2026)

Surgery Partners has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$19.8 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 1042.86% year-over-year to -$19.8 million; the TTM figure through Jun 2026 stood at -$205.5 million (up 12.78% YoY), while the FY2025 annual figure was -$246.6 million, up 49.52% from the prior year.
• Cash from Investing Activities came in at -$19.8 million for Q2 2026 at Surgery Partners, down from -$13.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q2 2025 to a low of -$244.1 million in Q2 2024.
• Average Cash from Investing Activities over 5 years is -$72.3 million, with a median of -$64.4 million recorded in 2023.
• Year-over-year, Cash from Investing Activities surged 100.86% in 2025 and slumped 1042.86% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$72.2 million in 2022, then gained by 19.53% to -$58.1 million in 2023, then tumbled by 92.25% to -$111.7 million in 2024, then dropped by 12.89% to -$126.1 million in 2025, then jumped by 84.3% to -$19.8 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$19.8 million in Q2 2026, -$13.4 million in Q1 2026, and -$126.1 million in Q4 2025.